| |
| |
|
| Insider
Information: |
Parven Alvin S |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
7,568 |
|
|
Indirect Shares
|
3,880 |
|
|
| Direct
Value |
$1,381,160 |
|
|
|
Indirect Value
|
$708,100 |
|
|
| Total
Shares |
11,448 |
|
|
| Total
Value |
$2,089,260 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-06-15 |
7,568 |
2017-01-05 |
3,880 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-06-15 |
4 |
S |
$116.78 |
$97,511 |
D/D |
(835) |
7,568 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030 |
8,403 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-01-05 |
4 |
AS |
$133.65 |
$341,202 |
I/I |
(2,493) |
3,880 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-01-05 |
4 |
AS |
$133.95 |
$2,793,752 |
D/D |
(20,166) |
6,373 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-01-05 |
4 |
OE |
$26.64 |
$1,094,304 |
D/D |
20,166 |
26,539 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-08-22 |
4 |
S |
$136.53 |
$2,047,950 |
D/D |
(15,000) |
6,373 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-08-22 |
4 |
OE |
$18.01 |
$270,150 |
D/D |
15,000 |
21,373 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-08-15 |
4 |
S |
$135.51 |
$94,857 |
D/D |
(700) |
6,373 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
835 |
7,073 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-11-02 |
4 |
S |
$178.73 |
$159,963 |
D/D |
(895) |
4,645 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
5,540 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-11-11 |
4 |
S |
$195.66 |
$2,934,900 |
D/D |
(15,000) |
4,840 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-11-11 |
4 |
OE |
$18.01 |
$270,150 |
D/D |
15,000 |
19,840 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-05-13 |
4 |
OE |
$16.83 |
$206,605 |
D/D |
12,276 |
17,116 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-05-13 |
4 |
S |
$160.78 |
$1,973,735 |
D/D |
(12,276) |
4,840 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
895 |
5,735 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-02-11 |
4 |
S |
$174.06 |
$430,102 |
D/D |
(2,471) |
4,840 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2013-03-08 |
4 |
S |
$92.00 |
$286,580 |
D/D |
(3,115) |
7,311 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2013-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,471 |
11,195 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2012-11-19 |
4 |
S |
$90.74 |
$2,739,053 |
D/D |
(30,000) |
7,311 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2012-11-19 |
4 |
OE |
$10.84 |
$325,200 |
D/D |
30,000 |
37,311 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2012-06-08 |
4 |
S |
$91.01 |
$2,730,300 |
D/D |
(30,000) |
7,311 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2012-06-08 |
4 |
OE |
$8.18 |
$245,400 |
D/D |
30,000 |
37,311 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2012-03-05 |
4 |
B |
$84.95 |
$11,893 |
D/D |
140 |
7,451 |
2.39 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2012-02-21 |
4 |
S |
$81.51 |
$444,230 |
D/D |
(5,450) |
7,311 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
